Engineered endosymbionts that alter mammalian cell surface marker, cytokine and chemokine expression

oleh: Cody S. Madsen, Ashley V. Makela, Emily M. Greeson, Jonathan W. Hardy, Christopher H. Contag

Format: Article
Diterbitkan: Nature Portfolio 2022-08-01

Deskripsi

The establishment of non-pathogenic engineered endosymbionts through B. subtilis is presented, with the aim of delivering mammalian transcription factors to the host cell for therapeutics and research.